{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:13:33Z","timestamp":1788308013642,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2410-H-037-022-MY3"],"award-info":[{"award-number":["NSTC 114-2410-H-037-022-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006578","name":"Chi Mei Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006578","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["113CM-KMU-01"],"award-info":[{"award-number":["113CM-KMU-01"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aca.2025.344871","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:43:39Z","timestamp":1762645419000},"page":"344871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development and validation of UPLC\u2013MS\/MS method for detecting nootropic misuse in oral fluids: A step towards combating doping in Esports"],"prefix":"10.1016","volume":"1383","author":[{"given":"Kassim Ali","family":"Salum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2605-1813","authenticated-orcid":false,"given":"Meng-Tsang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hsin","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8989-5602","authenticated-orcid":false,"given":"Hung-Chih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8025-1755","authenticated-orcid":false,"given":"William Chih-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aca.2025.344871_bib1","series-title":"GrowNxt Digital","article-title":"What is esports? An introduction to competitive gaming","author":"Nagpal","year":"2023"},{"issue":"11","key":"10.1016\/j.aca.2025.344871_bib2","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1080\/17430437.2020.1819695","article-title":"The rise of E-Sports and potential for Post-COVID continued growth","volume":"23","author":"Kim","year":"2020","journal-title":"Sport Soc."},{"key":"10.1016\/j.aca.2025.344871_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.54254\/2753-7048\/43\/20240592","article-title":"The rise of E-Sports: the transformation from leisure entertainment to a global sports phenomenon","volume":"43","author":"Li","year":"2024","journal-title":"Lecture Notes in Edu. Psychol. Publ. Media"},{"issue":"11","key":"10.1016\/j.aca.2025.344871_bib4","article-title":"The prevalence and outlook of doping in electronic sports (Esports): an original study and review of the overlooked medical challenges","volume":"15","author":"S\u0142yk","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.aca.2025.344871_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.peh.2021.100205","article-title":"The \u201cbig red bull\u201d in the esports room: anti-doping, esports, and energy drinks","volume":"10","author":"Frias","year":"2022","journal-title":"Perform. Enhance. Health"},{"issue":"16","key":"10.1016\/j.aca.2025.344871_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/nu14163367","article-title":"Nootropics as cognitive enhancers: types, dosage and side effects of smart drugs","volume":"14","author":"Mal\u00edk","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.aca.2025.344871_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/17511321.2018.1459814","article-title":"Virtue(al) games\u2014real drugs","volume":"13","author":"Holden","year":"2019","journal-title":"Sport Ethics Philos."},{"key":"10.1016\/j.aca.2025.344871_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.chb.2021.106890","article-title":"The video gamer 500: performance-enhancing drug use and internet gaming disorder among adult video gamers","volume":"123","author":"Ip","year":"2021","journal-title":"Comput. Hum. Behav."},{"issue":"3","key":"10.1016\/j.aca.2025.344871_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/dta.140","article-title":"Oral fluid and hair in workplace drug testing programs: new technology for immunoassays","volume":"3","author":"Moore","year":"2011","journal-title":"Drug Test. Anal."},{"issue":"7","key":"10.1016\/j.aca.2025.344871_bib10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/anatox\/35.7.424","article-title":"Synthetic cannabinoids in oral fluid","volume":"35","author":"Coulter","year":"2011","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.aca.2025.344871_bib11","series-title":"[Table, Urine Drug Testing Window of Detection]","article-title":"Medications for opioid use disorder: for healthcare and addiction professionals, policymakers, patients, and families: substance abuse and mental health services administration (US)","year":"2018"},{"key":"10.1016\/j.aca.2025.344871_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.microc.2018.04.002","article-title":"Multivariate optimization techniques in analytical chemistry - an overview","volume":"140","author":"Ferreira","year":"2018","journal-title":"Microchem. J."},{"key":"10.1016\/j.aca.2025.344871_bib14","series-title":"ICH Harmonised Guideline Bioanalytical Method Validation and Study Sample Analysis M10","year":"2022"},{"issue":"23","key":"10.1016\/j.aca.2025.344871_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.11613\/BM.2013.009","article-title":"The effect of storage time and freeze-thaw cycles on the stability of serum samples","author":"Cuhadar","year":"2013","journal-title":"Biochem. Med."},{"issue":"22","key":"10.1016\/j.aca.2025.344871_bib16","doi-asserted-by":"crossref","first-page":"7279","DOI":"10.1039\/D0AN01379J","article-title":"Evaluation of swabs from 15 commercially available oral fluid sample collection devices for the analysis of commonly abused substances: doping agents and drugs of abuse","volume":"145","author":"Sobczak","year":"2020","journal-title":"Analyst"},{"issue":"11\u201312","key":"10.1016\/j.aca.2025.344871_bib17","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/dta.3580","article-title":"Determination of urinary deanol\u2010n\u2010oxide excretion profiles after ingestion of nutritional supplements containing deanol","volume":"15","author":"Krug","year":"2023","journal-title":"Drug Test. Anal."},{"issue":"4","key":"10.1016\/j.aca.2025.344871_bib18","first-page":"1","article-title":"Doping in esports: a review of nootropics and analytical methods for their detection","volume":"57","author":"Salum","year":"2024","journal-title":"Phy. Edu. J."},{"issue":"3","key":"10.1016\/j.aca.2025.344871_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/chromsci\/46.3.209","article-title":"Evaluation of BEH C18, BEH HILIC, and HSS T3 (C18) column chemistries for the UPLC-MS-MS analysis of glutathione, glutathione disulfide, and ophthalmic acid in mouse liver and human plasma","volume":"46","author":"New","year":"2008","journal-title":"J. Chromatogr. Sci."},{"issue":"10","key":"10.1016\/j.aca.2025.344871_bib20","first-page":"752","article-title":"Modern Trends and Best Practices in Mobile-Phase Selection in Reversed-Phase Chromatography","volume":"36","author":"Dong","year":"2018","journal-title":"LCGC North Am."},{"issue":"1","key":"10.1016\/j.aca.2025.344871_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.aca.2005.11.011","article-title":"A model for temperature effect on column efficiency in high-temperature liquid chromatography","volume":"558","author":"Yang","year":"2006","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.aca.2025.344871_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9673(01)81448-5","article-title":"Effect of mobile phase flow-rate on the recoveries and production rates in overloaded elution chromatography: a theoretical study","volume":"452","author":"Ghodbane","year":"1988","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.aca.2025.344871_bib23","doi-asserted-by":"crossref","first-page":"462867","DOI":"10.1016\/j.chroma.2022.462867","article-title":"MultiConditionRT: Predicting liquid chromatography retention time for emerging contaminants for a wide range of eluent compositions and stationary phases","volume":"1666","author":"Souihi","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.aca.2025.344871_bib24","series-title":"Encyclopedia of Separation Science","first-page":"4644","article-title":"Appendix 2. Essential guides to method development in supercritical fluid chromatography","author":"Schoenmakers","year":"2000"},{"key":"10.1016\/j.aca.2025.344871_bib25","series-title":"Handbook of Bioanalytics","first-page":"213","article-title":"Detection of psychoactive substances used in doping: screening and confirmation procedures","author":"Kwiatkowska","year":"2022"},{"key":"10.1016\/j.aca.2025.344871_bib26","article-title":"How to choose the best elution solvent for SLE?","author":"Marin","year":"2025","journal-title":"Biotage"},{"issue":"4","key":"10.1016\/j.aca.2025.344871_bib27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.talanta.2006.05.024","article-title":"Development of a multi-residue analytical methodology based on liquid chromatography\u2013tandem mass spectrometry (LC\u2013MS\/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters","volume":"70","author":"Gros","year":"2006","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/j.aca.2025.344871_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chroma.2007.10.029","article-title":"Trace determination of cannabinoids and opiates in wastewater and surface waters by ultra-performance liquid chromatography\u2013tandem mass spectrometry","volume":"1175","author":"Boleda","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.aca.2025.344871_bib29","series-title":"Sample Preparation Techniques in Analytical Chemistry","author":"Mitra","year":"2004"},{"issue":"3","key":"10.1016\/j.aca.2025.344871_bib30","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.3390\/molecules18033183","article-title":"The toxicological assessment of cyclopentyl methyl ether (CPME) as a green solvent","volume":"18","author":"Watanabe","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.aca.2025.344871_bib31","series-title":"Encyclopedia of Lipidomics","first-page":"1","article-title":"Lipid extraction: basics of the methyl-tert-butyl ether extraction","author":"Eggers","year":"2016"},{"key":"10.1016\/j.aca.2025.344871_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465142","article-title":"Evaluating C18 stationary phases with a positively charged surface for proteomic LC-MS applications using mobile phase acidified with reduced formic acid concentration","volume":"1730","author":"Jadeja","year":"2024","journal-title":"J. Chromatogr. A"},{"issue":"1","key":"10.1016\/j.aca.2025.344871_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10337-013-2569-5","article-title":"Simultaneous Determination of Fenproporex, Diethylpropione and Methylphenidate in Oral Fluid by LC-MS\/MS","volume":"77","author":"De C\u00e1ssia Mariotti","year":"2014","journal-title":"Chromatographia"},{"issue":"12","key":"10.1016\/j.aca.2025.344871_bib34","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1016\/j.xphs.2021.08.035","article-title":"Stability of pentoxifylline injection: application to neonatal\/pediatric care setting","volume":"110","author":"Senarathna","year":"2021","journal-title":"J. Pharmaceut. Sci."},{"issue":"6","key":"10.1016\/j.aca.2025.344871_bib35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/dta.421","article-title":"A validated HPLC method for the simultaneous determination of naftidrofuryl oxalate and its degradation product (metabolite), naftidrofuryl acid: applications to pharmaceutical tablets and biological samples","volume":"5","author":"Sabry","year":"2013","journal-title":"Drug Test. Anal."},{"issue":"8","key":"10.1016\/j.aca.2025.344871_bib36","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jat\/bkab063","article-title":"Short- and long-term stability of methylphenidate and its metabolites in blood","volume":"45","author":"Smith","year":"2021","journal-title":"J. Anal. Toxicol."},{"issue":"6","key":"10.1016\/j.aca.2025.344871_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3900","article-title":"Measurement of caffeine and its three primary metabolites in human plasma by HPLC-ESI-MS\/MS and clinical application","volume":"31","author":"Chen","year":"2017","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.aca.2025.344871_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpha.2011.09.005","article-title":"Determination of metabolite of nicergoline in human plasma by high-performance liquid chromatography and its application in pharmacokinetic studies","volume":"2","author":"Zheng","year":"2012","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.aca.2025.344871_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.taap.2017.11.011","article-title":"Systemic exposure of vinpocetine in pregnant sprague dawley rats following repeated oral exposure: an investigation of fetal transfer","volume":"338","author":"Waidyanatha","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.aca.2025.344871_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/FTD.0b013e318156e892","article-title":"Stability studies of principal illicit drugs in oral fluid: preparation of reference materials for external quality assessment schemes","volume":"29","author":"Ventura","year":"2007","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.aca.2025.344871_bib41","series-title":"World Anti-Doping Agency, Technical Letter \u2013 TL01","year":"2022"},{"key":"10.1016\/j.aca.2025.344871_bib42","series-title":"Comprehensive Organic Synthesis","first-page":"535","article-title":"8.15 reduction of SO and SO2 to S, S\u2013X to S\u2013H, and PO to P","author":"Gaumont","year":"2014"},{"key":"10.1016\/j.aca.2025.344871_bib43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jchromb.2013.01.027","article-title":"Determination of methylphenidate in plasma and saliva by liquid chromatography\/tandem mass spectrometry","volume":"923\u2013924","author":"Se\u00e7ilir","year":"2013","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.aca.2025.344871_bib44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.chroma.2013.01.057","article-title":"Separation of piracetam derivatives on polysaccharide-based chiral stationary phases","volume":"1281","author":"Ka\u017eoka","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.aca.2025.344871_bib45","series-title":"Comprehensive Analytical Chemistry","doi-asserted-by":"crossref","DOI":"10.1016\/bs.coac.2024.10.012","article-title":"The targeted analysis of new psychoactive substances in oral fluids","author":"Garc\u00eda-Atienza","year":"2024"},{"key":"10.1016\/j.aca.2025.344871_bib46","unstructured":"Salimetrics. Collection Methods: SalivaBio Oral Swab (SOS), Salimetrics (CS-5001.02, Rev. 17,06SEP2024);."},{"key":"10.1016\/j.aca.2025.344871_bib47","series-title":"TDSSA - Technical Document for Sport Specific Analysis","year":"2025"}],"container-title":["Analytica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267025012656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267025012656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:59:23Z","timestamp":1773806363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267025012656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":46,"alternative-id":["S0003267025012656"],"URL":"https:\/\/doi.org\/10.1016\/j.aca.2025.344871","relation":{},"ISSN":["0003-2670"],"issn-type":[{"value":"0003-2670","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of UPLC\u2013MS\/MS method for detecting nootropic misuse in oral fluids: A step towards combating doping in Esports","name":"articletitle","label":"Article Title"},{"value":"Analytica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aca.2025.344871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"344871"}}